NeoGenomics Schedules its Fourth Quarter and Full Year 2020 Earnings Release for February 24, 2021
Press Release
Read More
Parexel and NeoGenomics Announce Strategic Collaboration in Precision Medicine to Improve Study Designs and Accelerate Patient Matching in Oncology Clinical Trials
Press Release
Read More
NeoGenomics and Tempus Join the Access to Comprehensive Genomic Profiling Coalition
Press Release
Read More
Real-world PD-L1 test utilization and analytical concordance of the PD-L1 IHC 28-8 and 22C3 assays in patients with breast cancer
Literature
Read More
Circulating tumor DNA (ctDNA) clearance as a biomarker in patients with locally advanced NSCLC following chemoradiation
Literature
Read More
NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes
Press Release
Read More